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2 Abstract 26
Intestinal intraepithelial lymphocytes (IEL) comprise a diverse population of cells 27 residing in the epithelium at the interface between the intestinal lumen and the sterile 28 environment of the lamina propria. Because of this anatomical location, IEL are 29 considered critical components of intestinal immune responses. Indeed, IEL are 30 involved in many different immunological processes ranging from pathogen control to 31 tissue stability. However, maintenance of IEL homeostasis is incompletely understood. 32 In this report we present evidence that osteopontin, a glycophosphoprotein with diverse 33 roles in biomineralization, cell-mediated immunity, and inflammation, is important for 34 maintaining normal levels of IEL. Mice in which the osteopontin gene (Spp-1) is 35 disrupted present decreased levels of IEL subtypes, such as TCRαβ and TCRγδ IEL in 36 the intestine, an effect not observed for lymphocytes in other immune compartments 37 such as spleen or lamina propria, indicating an epithelium-specific effect. In vitro 38 experiments show that mouse and human IEL survival is improved by culture with 39 Introduction 45
One of the largest immunological compartments in the body is comprised of 46 intraepithelial lymphocytes (IEL), a group of immune cells interspaced between the monolayer of intestinal epithelial cells (IEC). IEL can be divided into two groups based 48 on T cell receptor (TCR) expression. 1, 2, 3 TCR + IEL express αβ or γδ chains. TCRαβ + 49 IEL can be further subdivided into different populations such as TCRαβ + CD4 + , 50 TCRαβ + CD4 + CD8αα + , TCRαβ + CD8αβ + , and TCRαβ + CD8αβ + CD8αα + cells. TCR neg IEL 51 comprise innate lymphoid cells (ILC) 4, 5, 6 and lymphocytes characterized by expression 52 of intracellular CD3γ chains (iCD3 + ), some of which express CD8αα (iCD8α cells). 7, 8 53 Because of their anatomical location, IEL function as sentinels between the 54 antigenic contents of the intestinal lumen and the sterile environment under the basal 55 membrane of the epithelium. Indeed, TCRγδ IEL surveil for pathogens, 9 secrete 56 antimicrobials conferring protection against pathobionts, 10 and protect from intestinal 57 inflammation. 11 TCRγδ IEL are also involved in protecting the integrity of damaged 58 epithelium after dextran sodium sulphate (DSS)-induced colitis, 12 and are responsible, 59 along with other IEL, for preserving IEC homeostasis. 13, 14 Other IEL, such as 60 conventional effector CD8 T cells that migrate into the epithelium, can protect against 61
Toxoplasma infection, 15 and reside in this organ as memory cells. 16, 17 IEL such as 62 TCRαβ + CD4 + CD8αα + cells can prevent development of colitis in an adoptive transfer 63 model. 18 TCR neg IEL such as iCD8α cells confer protection against Citrobacter 64 rodentium infection and may protect against necrotizing enterocolitis in neonates, 8 but 65 these cells can also promote intestinal inflammation in some experimental conditions. 19 66 iCD3 + IEL are involved in malignancies associated with celiac disease. 7 67
Osteopontin is a glycosylated phosphoprotein, encoded by the Spp-1 gene, 68 originally characterized as part of the rat bone matrix. 20, 21 Osteopontin is a versatile 69 molecule involved in many physiological processes, that include immunological roles, 70 such as macrophage chemotaxis, 22 induction of Th1 responses, 23 suppression of T cell 71 activated-induced cell death, 24 inhibition of natural killer (NK) cell apoptosis and 72 promotion of NK cell responses, 25 and modulation of dendritic cell function. 26 The role of 73 osteopontin during intestinal inflammation is diverse. For example, Spp-1-deficient mice 74 present with milder disease in the trinitrobenzene sulphonic acid 27 and DSS models of 75 4 colitis. 28 In humans with inflammatory bowel diseases (IBD), plasma osteopontin is 76 significantly increased as compared to normal individuals. 29, 30 Some reports indicate 77 that osteopontin is downregulated in the mucosa of Crohn's disease (CD) patients, 31 78 whereas other groups have reported higher osteopontin expression in the intestines of 79 individuals with CD and ulcerative colitis (UC) compared with healthy controls. 29, 32 80 Because of its potential involvement in IBD, this molecule could be a potential 81 biomarker for IBD, 33 and has been explored as a potential therapeutic target in clinical 82 trials. 34 These reports clearly underscore the importance of osteopontin in intestinal 83 inflammation and warrant further investigation of this molecule in mucosal immune 84
responses. 85
Recently, it was reported that the frequency and number of TCRγδ IEL were 86 reduced in osteopontin-deficient mice, while TCRαβ IEL numbers remained similar in 87 comparison to wild type controls. 35 However, in vitro neutralization of IEL-derived 88 osteopontin resulted in decreased survival of TCRγδ and TCRαβ IEL, 35 confounding the 89 in vivo results. Moreover, because of the IEL diversity present in the intestine, more 90 detailed analysis is required to determine the survival requirements of different IEL 91 populations. Herein, we provide substantial in vitro and in vivo evidence indicating that 92 osteopontin promotes the survival of TCRγδ and TCRαβ IEL, including subpopulations 93 of these cells, such as: TCRαβ + CD4 + , TCRαβ + CD4 + CD8αα + and TCRαβ + CD8αα + cells. 94
We also show that the survival effect is not only confined to murine IEL, but osteopontin 95 also promotes the survival of human IEL. Additionally, osteopontin promotes a pro-96 apoptotic transcriptional profile, underscoring its role as a survival stimulus. Moreover, 97
we show that the effect of osteopontin in IEL survival is mediated by CD44, a known 98 receptor for osteopontin conspicuously expressed by IEL and regulatory T cells in the 99 intestinal mucosa. Lastly, using two different models of intestinal inflammation, we 100 present evidence indicating that the lack of osteopontin results in increased disease 101 susceptibility. 102 103 104 105 106
Results 107
Osteopontin-deficient mice contain a reduced IEL compartment. 108
To determine the role of osteopontin in IEL homeostasis, we analyzed the IEL 109 compartment of wild-type (WT) and Spp-1 -/mice. Flow cytometry studies revealed a 110 reduction in the proportion of total IEL in the small intestine of Spp-1 -/mice compared 111 with WT mice (Fig. 1a , FSC vs SCC dot plots). The percentages of certain TCRβ + IEL 112 subpopulations, such as TCRβ + CD4 + and TCRβ + CD4 + CD8αα + were reduced in Spp-1 -/-113 mice, whereas others, such as TCRβ + CD8αα + cells were similar among both groups of 114 mice ( Fig. 1a dot plots) . The percentages of TCRγδ + and TCR neg IEL, such as iCD8α 115 cells, were similar between WT and Spp-1 -/mice. In terms of total cell numbers, Spp-1 -/-116 mice presented a significant decrease in TCRγδ + IEL, corroborating the observations 117 made by others (Fig 1a graphs) . 35 However, we observed total cell number reduction in 118 TCRβ + IEL due to the decline of TCRβ + CD4 + , TCRβ + CD8α + and TCRβ + CD4 + CD8α + in 119 the small intestine IEL of osteopontin-deficient mice. The numbers of TCR neg IEL and 120 the subpopulation iCD8α cells were similar among WT and Spp-1 -/mice (Fig 1a  121 graphs). While colon IEL numbers from Spp-1 -/mice showed a similar pattern as in the 122 small intestine, the numbers of TCR neg IEL from these mice were significantly reduced 123 as compared with WT mice (Fig. 1b) . Interestingly, osteopontin-deficiency did not affect 124 spleen T lymphocytes ( Fig. 1c ), or lamina propria CD19 + , TCRβ + CD4 + and TCRβ + CD8 + 125 cells ( Fig. 1d ), suggesting that the major influence of this molecule is confined to the 126 intestinal IEL compartment. 127
128
Increased apoptosis and decreased cellular division in IEL from osteopontin-deficient 129
mice. 130
To investigate whether the reduction in IEL numbers in Spp-1 -/mice was due to 131 increased cell death, we determined the levels of early/late apoptosis and necrosis. As 132 shown in Fig. 2a , all IEL populations isolated from WT and Spp-1 -/mice analyzed 133 presented similar levels of cells in early apoptosis (annexin V + 7AAD neg ). We observed a 134 significantly higher percentage of late apoptotic (annexin V + 7AAD + ) TCRγδ + and 135 TCRβ + CD4 + CD8α + , and a near significant higher percentage of TCRβ + CD4 + IEL from 136 6 Spp-1 -/mice. Because the cell death and proliferation rates are inversely related, we 137 investigated the proliferation frequencies in different IEL populations. TCRβCD4 + , 138 TCRβCD4 + CD8α + and TCRβ + CD8αα + IEL derived from Spp-1 -/mice presented lower 139 levels of dividing cells as indicated by the expression of Ki67 (Fig. 2b) , corroborating the 140 increase in apoptosis observed in IEL from osteopontin-deficient mice. However, 141 despite the numbers of TCRγδ IEL were reduced in Spp-1 -/mice and presented an 142 increased frequency of cells in late apoptosis, TCRγδ IEL from Spp-1 -/mice showed 143 similar proliferation levels as cells derived from WT mice. 144
Overall, these results show that in the absence of osteopontin, IEL present 145 higher apoptosis and reduced cell proliferation, which may account for the decreased 146 IEL numbers observed in osteopontin-deficient mice. 147 148 CD44 deficiency affects the IEL compartment. 149 CD44 is one of the receptors for osteopontin 36 and is also expressed by IEL ( Fig.  150 3a). Therefore, we reasoned that if osteopontin provides a survival signal via CD44, the 151 absence of this receptor should also result in decreased numbers of IEL. Most IEL 152 populations from CD44 -/mice presented a trend of decreased numbers in both the 153 small intestine and colon ( Fig. 3b and 3c ) in comparison to IEL from wild type mice. The 154 difference was significant for total colon TCRβ + and subpopulations such as 155 TCRβ + CD4 + , and TCRβ + CD8αα + IEL. Interestingly, TCR neg cells also presented a 156 reduction in numbers in the small intestine and colons of CD44 -/mice. These results 157
show similarities between the IEL compartment observed in Spp-1 -/and CD44 -/mice, 158 suggesting a role for the osteopontin-CD44 interaction for IEL survival. 159
As shown in Fig.1 , the effect of osteopontin in steady-state levels seems to affect 160 only the IEL compartment. To determine whether the frequencies of other CD44 + cells 161 in other immune compartments are affected by oseteopontin, we analyzed TCRγδ + , 162 TCRαβ + CD4 + and TCRαβ + CD8 + T cells from the spleen. The fraction of CD44 + cells in 163 these three populations was undistinguishable between WT and Spp-1 -/mice (Fig 3c) , 164
indicating that, at steady state levels, osteopontin does not affect the frequency of 165 activated CD44 + spleen T cells. 166 167 7
Osteopontin promotes survival of IEL in a To further investigate the role of osteopontin in IEL survival, we used an in vitro 169 system. For this purpose, first, we isolated total IEL (CD45 + cells from IEL preparations) 170 from WT mice and cultured them under different conditions. CD45 + IEL cultured in 171 media alone resulted in ~30% cell survival after 24 h of culture, followed by a constant 172 decrease thereafter. However, addition of recombinant osteopontin resulted in improved 173 IEL survival, to around 50% 24 h post culture ( Fig. 4a ). Recombinant osteopontin 174 maintained increased IEL survival compared with media alone at 48 and 72 h post 175 culture. However, when IEL were cultured in the presence of recombinant osteopontin 176 and anti-osteopontin antibodies, cell survival was blunted to levels similar as observed 177 for media alone, indicating that IEL in vitro survival was mediated by recombinant 178 osteopontin ( Fig. 4a ). IEL incubated only with anti-osteopontin antibodies behaved 179 similarly as cells cultured in media alone, suggesting that under these experimental 180 conditions either IEL did not produce osteopontin or IEL-derived osteopontin was not a 181 factor in cell survival. These results are in contrast to the work of Ito et al., that showed 182 that IEL-derived osteopontin was important for their in vitro survival; 35 differences in 183 culture systems between the two groups may account for this discrepancy. To 184 determine whether the observed osteopontin-mediated IEL survival was facilitated by 185 CD44, IEL were cultured in the presence of recombinant osteopontin and anti-CD44 186 antibodies. As shown in Fig. 4a , CD44 blockage resulted in decreased IEL survival 187 similar to that observed for media alone, especially at 48 and 72 h post-culture. 188
Moreover, CD45 + IEL derived from CD44-deficient mice cultured with recombinant 189 osteopontin presented similar survival as IEL cultured in media alone ( Fig. 4b) , 190 underscoring the importance of the interaction between osteopontin and CD44 in IEL 191 survival. We then investigated the survival of different FACS-enriched IEL 192 subpopulations from WT mice when cultured in the presence or absence of recombinant 193 osteopontin. Increased survival was observed in TCRγδ + , TCRβ + CD4 + , TCRβ + CD8α + 194 and TCRβ + CD4 + CD8α + IEL when recombinant osteopontin was included in the media; 195 however, the effect on survival was observed at different time points depending on the 196 IEL population analyzed ( Fig. 4c ). Addition of anti-CD44 to the cultures blunted the 197 osteopontin effect (Fig. 4c) . 198 8 To determine whether osteopontin influences the survival of spleen T cells, we 199 first incubated total splenocytes from WT mice in the presence or absence of 200 recombinant osteopontin. As shown in Fig. 4d , survival of total spleen T cells was not 201 affected by osteopontin. Moreover, FACS-enriched TCRβ + CD44 hi spleen cells from WT 202 and Spp-1 -/mice cultured in the presence or absence of osteopontin and/or anti-CD44 203 presented no difference in their survival (Fig. 4e ), indicating that osteopontin 204 preferentially influences the in vitro survival of IEL via CD44 but not of total or CD44 + 205 spleen T cells. 206
The immune system of mice maintained in specific pathogen-free conditions 207 more closely resembles that of human neonates rather than adults. 37 Therefore, to 208 determine whether our findings with murine IEL are relevant to humans, we isolated 209 total IEL from human neonates and cultured them in the presence or absence of 210 recombinant osteopontin. Human IEL survived better in the presence of recombinant 211 osteopontin than in its absence, and addition of anti-CD44 blunted the cytokine effect 212 ( Fig. 4f ), in parallel to the results observed with mouse IEL. To determine the effect of 213 osteopontin on other human lymphocytes, we employed PBMC from healthy adults, as 214 we were unable to obtain PBMCs from the same neonate individuals for this purpose. 215
As shown in Figure 4g , PBMC survival was not enhanced or reduced by any of the 216 treatments used, which corroborates an intestinal IEL specific effect. Our results 217 indicate that osteopontin promotes survival of murine and human IEL, and at least in the 218 mouse system, this effect is mediated by CD44. 219 220
Osteopontin induces a survival program in IEL 221
The in vivo and in vitro studies presented in the previous sections indicate that 222 osteopontin is an important cytokine involved in the survival of IEL. To investigate 223 whether osteopontin, or its absence, alters the IEL transcription profile, we isolated RNA 224 from FACS-enriched TCRγδ + , TCRβ + CD4 + , TCRβ + CD8α + and TCRβ + CD4 + CD8α + IEL 225 derived from naïve WT and Spp-1 -/mice, and determined the expression of genes 226 involved in preventing apoptosis. Comparison of genes expressed in IEL from WT and 227
Spp-1 -/mice showed that TCRγδ + cells from WT animals had more differentially 228 expressed anti-apoptotic genes in comparison to the other IEL populations (Fig. 5a ). 229 9 TCRβ + CD8α + IEL presented little differential expression among the anti-apoptotic genes 230 analyzed. On the other hand, TCRβ + CD4 + and TCRβ + CD4 + CD8α + IEL differentially 231 expressed some of these genes ( Fig. 5a ). Birc2, a known inhibitor of apoptosis in 232 malignancies, 38 was one of the genes consistently differentially expressed in most IEL 233 analyzed from WT mice, including TCRβ + CD4 + CD8α + cells (Fig. 5b ). Other anti-234 apoptotic genes with higher expression in WT IEL were Prdx2, Polb, Dffa, Bric5 and 235
Bcl10. Overall, these results indicate that osteopontin induces the expression of anti-236 apoptotic genes, but the gene profile varies between different IEL populations. 237
Because addition of recombinant osteopontin rescued wild type-derived CD45 + 238 IEL survival when cultured in vitro (Fig. 4a ), we interrogated whether addition of this 239 cytokine in cultured wild type IEL modifies their gene expression profile. For this 240 purpose, we cultured FACS-enriched CD45 + IEL from wild type mice in the presence or 241 absence of osteopontin. Twenty-four hours post-culture, cells were collected, RNA 242 extracted, sequenced and the gene expression profile determined. As recovery of 243 sufficient cells for gene expression profile analysis after 24 h of culture from individual 244 IEL populations was limiting, total CD45 + IEL were used as an alternative approach. 245
Gene set enrichment analysis (GSEA) revealed that IEL cultured in the presence of 246 recombinant osteopontin express genes associated with retinoid X receptor (RXR) 247 functions ( Fig. 5c and 5d ). This set included genes encoding products such as the 248 vitamin D receptor (VDR), which dimerizes with RXR and modulates osteopontin gene 249 transcription by binding to its promoter region, 39 and may induce a feedback loop in 250 osteopontin-expressing IEL. GSEA also showed that IEL cultured in media alone 251 present enriched pathways related to apoptosis, degradation of p27/p21 and 252 downregulation of genes in Tregs ( Fig. 5c and 5d ). These sets included genes coding 253 for proteasomal subunits, genes associated with cell cycle regulation (cyclin a2 and e1), 254 and genes involved in programmed cell death pathways such as, caspases, Uba52, and 255
Maged1. These results indicate that in vitro IEL exposure to osteopontin has an impact 256 on the IEL gene transcription profile. However, it is important to consider that use of 257 total CD45 + IEL as the source for RNA increases variability in the results due to the 258 different IEL populations present in the CD45 + compartment. 259 260
Osteopontin serves as checkpoint for development of intestinal inflammation 261
We reasoned that if osteopontin deficiency affects the IEL compartment, and proper 262 homeostasis of these cells is critical for protection against inflammation, then Spp-1 -/-263 mice may be susceptible to spontaneous intestinal inflammation. For these purposes we 264 monitored female Spp-1 -/mice from the time of weaning until 32 weeks of age. These 265 mice gained weight during the observation period but not as much as wild type control 266 females ( Fig. 6a ) and presented normal small intestine ( Fig. 6b ) and colon (not shown) 267 architecture without signs of inflammation. However, spontaneous inflammation may 268 become evident if another molecule involved in IEL homeostasis is disrupted. For this 269 purpose, we crossed Spp-1 -/mice with thymus leukemia (TL) antigen deficient mice. TL 270 is expressed in IEC and preferentially binds to CD8αα homodimers on IEL, controlling 271 their effector functions and proliferation. 40 While TL-deficient animals do not develop 272 spontaneous intestinal inflammation, when crossed to a susceptible strain, the offspring 273 present an early onset and increased incidence of spontaneous intestinal 274 inflammation. 41 Therefore, it is possible that disruption of two systems involved in IEL 275 homeostasis, the TL-CD8αα and the osteopontin-CD44, may result in spontaneous 276 intestinal inflammation. Spp-1 -/-TL -/mice also gained weight during all the observation 277 period but at lower levels than WT and Spp-1 -/mice ( Fig. 6a ; for figure clarity, statistical 278 significance at the relevant time points is presented in the figure legend). Interestingly, 279 analysis of ileum pathology showed an increase in IEL and lamina propria inflammatory 280 foci in Spp-1 -/-TL -/in comparison to WT and Spp-1 -/mice ( Fig. 6b and 6c ). These 281 results indicate that in the proper context, the absence of osteopontin may lead to 282 spontaneous intestinal inflammation, underscoring its importance as an intestinal 283 checkpoint. 284 285
Osteopontin prevents intestinal inflammation but not migration into the epithelium. 286
We have provided evidence indicating that the IEL deficiency observed in Spp-1 -/-287 mice is due to IEL survival; however, it is possible that osteopontin also affects 288 migration of T cells into the epithelium. To test this hypothesis, we adoptively 289 transferred total spleen T cells from WT mice into Rag-2 -/or Spp-1 -/-Rag-2 -/recipient 290 mice, and after 7 days we determined the number of cells migrating into the intestinal 291 11 epithelium. Both TCRβ + CD4 + and TCRβ + CD8α + cells migrated similarly into the 292 epithelium of Rag-2 -/or Spp-1 -/-Rag-2 -/recipient mice (Fig. 7a ), indicating that 293 osteopontin does not influence the migration of these cells into the intestinal mucosa. 294
We did not analyze spleen-derived TCRγδ cells because their numbers in the inoculum 295 were very low and these cells do not reconstitute the mucosa properly. Interestingly, 296 reconstitution analysis at 28 days post transfer showed a reduction in the total number 297 of TCRβ + CD4 + and TCRβ + CD4 + CD8α + cells (Fig. 7b) , which resembled what was 298 observed in Spp-1-deficient mice (Fig. 1a ). On the other hand, the numbers of adoptive 299 transferred TCRβ + CD8α + cells recovered were similar between Rag-2 -/or Spp-1 -/-Rag-300 2 -/recipient mice at 28 days post transfer ( Fig. 7b ). To prevent the development of 301 intestinal inflammation in Rag-2 -/recipient mice, we transferred total T cells, which 302 includes regulatory T cells. To our surprise, Spp-1 -/-Rag-2 -/recipient mice lost more 303 weight than Rag-2 -/mice ( Fig. 7c ) and presented increased colon inflammation ( Fig.  304 7d), suggesting that the absence of osteopontin in the host promoted disease 305 development. To test whether CD44, as a receptor for osteopontin, was also involved in 306 disease development in this system, we adoptively transferred total T cells from CD44 -/-307 donor mice into Rag-2 -/and Spp-1 -/-Rag-2 -/recipient mice. Rag-2 -/mice that received 308 total spleen T cells from WT mice did not lose weight, whereas Rag-2 -/and Spp-1 -/-Rag-309 2 -/recipient mice that received spleen cells from CD44 -/donor mice lost weight 310 comparably starting at 2 weeks post transfer (Fig. 7e) , with clear signs of intestinal 311 inflammation (Fig. 7f) . 312
Overall, this evidence indicates that adoptive transfer of total T cells into Spp-1 -/-313 Rag-2 -/mice result in similar TCRβ + CD4 + and TCRβ + CD8α + T cell migration into the IEL 314 compartment at 7 days after transference; however, the total number of TCRβ + CD4 + 315 and TCRβ + CD4 + CD8α + T were significantly reduced in an osteopontin-deficient 316 environment. Unexpectedly, decreased IEL reconstitution was accompanied by 317 intestinal inflammation. These results suggest that host-derived oseopontin and 318 expression of CD44 on the transferred T cells, are important for preventing development 319 of intestinal inflammation even in the presence of regulatory T cells. 320 321
Osteopontin sustains Foxp3 expression in Tregs

12
We expected that transferring total T cells into Spp-1 -/-Rag-2 -/mice would result in 323 protection against intestinal inflammation similar to that observed for Rag-2 -/recipient 324 mice, due to the presence of regulatory T cells in the inoculum. However, because 325 disease was observed in Spp-1 -/-Rag-2 -/recipient mice, we investigated the fate of 326 regulatory T cells in the presence or absence of osteopontin. Regulatory T cells are 327 known to express CD44, which when ligated, promotes sustained Foxp3 expression. 42 328
Thus, we hypothesized that binding of osteopontin to CD44 is a potential signal that 329 maintains proper Foxp3 expression. To test this possibility, we cultured CD4 T cells 330 derived from the intestinal mucosa from RFP-Foxp3 mice in the presence or absence of 331 recombinant osteopontin, with or without anti-CD44. After 72 h of culture, there was an 332 increase in the percentage of RFP + cells in the presence of osteopontin, which was 333
blunted with the addition of anti-CD44 antibodies (Fig. 8a) . Figure 8b shows the 334 combined fold increase over the untreated cells. 335
To test whether osteopontin sustains Foxp3 expression in vivo, we sorted splenic 336 RFP + cells from RFP-Foxp3 reporter mice and adoptively transferred them into Rag-2 -/-337 or Spp-1 -/-Rag-2 -/recipient mice. Eight weeks after transfer, IEL were isolated and the 338 percentage of donor-derived (CD45 + TCRβ + CD4 + ) RFP + cells was determined (Fig. 8c,  339 dot plots). Rag-2 -/mice presented a trend of higher percentage of donor-derived cells in 340 the IEL compartment than Spp-1 -/-Rag-2 -/recipient mice (Fig 8d) . Approximately 10% of 341 the donor-derived cells from Rag-2 -/recipient mice remained RFP + , whereas only 4% of 342 cells recovered from Spp-1 -/-Rag-2 -/recipient mice remained RFP + (Fig. 8e) promoting T cell survival. 24 Using an in vitro system, we showed that TCR + IEL rapidly 366 die in the absence of osteopontin, whereas IEL cultured in the presence of osteopontin 367 presented increased in vitro survival (Fig. 4) . It is important to notice the differential 368 behavior of cultured IEL subpopulations, e.g., the survival of TCRγδ + and 369 TCRβ + CD4 + CD8α + IEL is less than 50% after 24 h post culture decreasing to around 370 10% by 72 h, and it is at this point that the effect of osteopontin is more evident for 371 these cells. On the other hand, TCRβ + CD4 + and TCRβ + CD8α + IEL have a better 372 survival after 24 h (more than 50%), whereas the osteopontin effect is evident for the 373 former cells starting at 48 h. These results indicate that each IEL subpopulation possess 374 different survival kinetics, but appear to have a similar requirement for osteopontin for 375 their survival. 376
Because IEL are considered to be in a "semi-activated" state, 45 osteopontin 377 appears to primarily affect activated T cells, which express CD44. Interestingly, splenic 378 CD44 + T cell numbers are similar in wild type and Spp-1 -/mice ( Fig. 3c ), suggesting 379 that osteopontin does not affect the overall effector T cell population. Moreover, in vitro 380 survival of CD44 + spleen T cells is not affected by addition of osteopontin (Fig. 4e ). It is 381 important to note that previous reports have demonstrated a pivotal role for osteopontin 382 as an enhancer for the survival of effector Th17 cells, particularly during brain 383 14 inflammation; 24 however, whereas this group studied differentiated Th17 cells in the 384 context of brain inflammation our results are based on CD44 + T cells in naïve animals. 385
In the adoptive transfer experiments reported here, donor CD4 T cells from wild 386 type mice reconstituted the IEL compartment of Spp-1 -/-Rag-2 -/recipient mice less 387 efficiently than in Rag-2 -/recipient mice (Fig. 7) , suggesting that an environment 388 capable of producing osteopontin is important for proper cell survival. However, transfer 389 of T cells from osteopontin-deficient donor mice into Rag-2 -/recipient mice resulted in 390 reduced survival rates in the spleen and lymph nodes in comparison to donor T cells 391 from wild type donor mice. 25 These results indicate that intrinsic T cell-derived 392 osteopontin is critical for normal cell reconstitution in secondary lymphoid organs 393 whereas T cells present in the IEL compartment present an increase dependency for 394 their survival on osteopontin derived from the environment. 395
Adoptive transfer of total spleen T cells into immunodeficient hosts, such as Rag-396 2 -/mice, results in cellular reconstitution and protection from T cell-mediated colitis due 397 to the presence of regulatory T cells. 46, 47 Surprisingly, when recipient Rag-2 -/mice were 398 deficient in osteopontin (Rag-2 -/-Spp-1 -/animals), mice developed colitis even in the 399 presence of regulatory T cells, indicating that environmental osteopontin is important for 400 maintaining regulatory T cell function (Fig. 7) . This was evident when transfer of 401 regulatory T cells (RFP-Foxp3 + cells) into Spp-1 -/-Rag-2 -/hosts resulted in lower 402 recovery of RFP + cells from the intestinal epithelium in comparison to cells transferred 403 into Rag-2 -/hosts ( Fig. 8c and d) . Therefore, similar to other IEL, regulatory T cells 404 appear to be responsive to osteopontin via CD44, but in this case osteopontin helps to 405 sustain the levels of inflammation. a Weights of WT, Spp-1 -/and Spp-1 -/-TL -/female mice were monitored for 507 seven months starting at weaning age (n = 3 to 5). Statistical difference for: WT vs Spp-508 1 -/mice was P<0.05 or P<0.01 between week 6 to 24; WT vs Spp-1 -/-TL -/mice was 509 P<0.005 or P<0.001 between week 6 to 32; and Spp-1 -/vs Spp-1 -/-TL -/mice was 510 Mice. CD44 -/-, Rag-2 -/-, Spp-1 -/and RFP-Foxp3 reporter mice on the C57BL/6 556 background were obtained from the Jackson Laboratories. TL -/mice were developed in 557 our laboratory as previously described. 41 To homogenize the microbiome of vendor-558 derived mice, we co-housed or bred mice with established WT C57BL/6 mice from our 559 colony. Spp-1 -/-Rag-2 -/mice were generated in our colony by breeding Spp-1 +/with 560 Rag-2 +/mice. Spp-1 -/-TL -/mice were generated in our colony by breeding Spp-1 +/with 561 TL +/mice. Mice were maintained in accordance with the Institutional Animal Care and 562
Use Committee at Vanderbilt University. 563 564 IEL isolation. IEL were isolated by mechanical disruption as previously reported. 41 565
Briefly, after flushing the intestinal contents with cold HBSS and removing excess 566 mucus, the intestines were cut into small pieces (~1cm long) and shaken for 45 minutes 567 20 at 37°C in HBSS supplemented with 5% fetal bovine serum and 2 mM EDTA. 568 Supernatants were recovered and cells isolated using a discontinuous 40/70% Percoll 569 (General Electric) gradient. To obtain lamina propria lymphocytes, intestinal tissue was 570 recovered and digested with collagenase (187.5 U/ml, Sigma) and DNase I (0.6 U /ml, 571 Sigma). Cells were isolated using a discontinuous 40/70% Percoll gradient. 572 573 Human samples. The Vanderbilt University Medical Center Institutional Review Board 574 approved sample collection (IRB# 090161 and 190182) . All samples were de-identified 575 and written informed consent was obtained. Peripheral blood mononuclear cells were 576 isolated by ficoll gradient from unidentified healthy adult volunteers as previously 577 described. 50 A pathologist from the Vanderbilt Children's Hospital provided fresh 578 intestinal tissue specimens from infants. Isolation of human cells associated with the 579 intestinal epithelium was performed as previously described. 51 Briefly, tissue was cut in 580 small ~1 cm pieces and incubated with slow shaking for 30 minutes at room 581 temperature in HBSS (without calcium and magnesium) supplemented with 5% fetal 582 bovine serum, 5mM EDTA and an 1% antibiotic mix (pen-strep-AmphoB; Fisher-Lonza). 583
After incubation, cells in the supernatant were recovered. 584
585
Reagents and flow cytometry. Fluorochrome-coupled anti-mouse CD4, -CD44, -CD45, -586
CD8α, -TCRβ, -TCRγδ, Ki69 and isotype controls were purchased from Thermofisher or 587 BD Biosciences. Annexin V and 7AAD were purchased from BD biosciences. All 588 staining samples were acquired using a FACS Canto II or 4-Laser Fortessa Flow 589 System (BD Biosciences) and data analyzed using FlowJo software (Tree Star 
